我国公立医院药品带量采购制度实施状况研究

发布时间：2018-04-09 13:54

本文选题：公立医院　切入点：药品采购　出处：《中国药房》2017年31期

【摘要】：目的:为完善我国公立医院药品采购制度提供参考。方法:检索2015年国务院7号和国家卫生和计划生育委员会70号文发布后各省药品集中采购文件,搜集药品中标数据,分析药品带量采购的形式及实施情况。结果:带量采购包括分散带量采购、国家集中带量采购和省级集中带量采购3种形式。分散带量采购存在实际采购价格不透明、个别省份采购类似"二次议价"等情况;国家集中带量采购执行情况良好;省级集中带量采购尚未大规模执行,仅上海进行集中带量采购试点,且试点效果较好。结论:为推进带量采购,建议在政府公开文件中明确"带量采购"的定义;公开分散带量采购的实际采购价格;各省试行不区分质量层次的集中带量采购;改良区分质量层次的集中带量采购;完善配套措施,如医院采购系统和省际采购平台、医保资金预付机制等。
[Abstract]:Objective: to provide a reference for the improvement of drug procurement system in public hospitals in China.Methods: after the publication of document No. 7 of the State Council and the National Health and Family Planning Commission in 2015, the centralized purchasing documents of drugs were collected, and the data of drug winning were collected, and the form and implementation of drug belt purchase were analyzed.Results: the purchasing of belt volume included three forms: decentralized purchasing, national centralized purchasing and provincial centralized purchasing.The actual purchase price is not transparent, and the procurement of individual provinces is similar to that of "second bargaining price"; the implementation of centralized procurement by the State is good; and the procurement of centralized belt volume at the provincial level has not yet been carried out on a large scale.Shanghai only carries on the concentration belt quantity purchase pilot, and the pilot effect is good.Conclusion: in order to promote the purchase with quantity, it is suggested that the definition of "purchase with quantity" be clearly defined in the public documents of the government, the actual purchase price of decentralized purchase should be made public, the centralized purchasing without distinguishing quality level should be tried out in each province.Improving the centralized purchasing with different quality levels, perfecting the supporting measures, such as hospital purchasing system and provincial purchasing platform, medical insurance fund prepayment mechanism and so on.
【作者单位】：沈阳药科大学工商管理学院;沈阳药科大学国际食品药品政策与法律研究中心;
【分类号】：R951

【相似文献】